Line with biological replicatesa | Restriction endonuclease combination | Genome coverage (%)b | Cytosine coverage (%)c | Efficiencyd | Number of analyzed cytosine sites | ||
---|---|---|---|---|---|---|---|
CG | CHG | CHH | |||||
(millions)e | |||||||
Plant-RRBS | Â | Â | Â | Â | Â | Â | Â |
 Control-1 | MspI-DpnII | 39.6 | 42.8 | 1.1 | 15.3 | 13.1 | 48.1 |
 Control-2 | MspI-DpnII | 42.3 | 44.9 | 1.1 | 15.6 | 13.6 | 51.1 |
 Control-3 | MspI-DpnII | 30.8 | 32.8 | 1.1 | 11.6 | 10.0 | 37.0 |
 Control-4 | MspI-DpnII | 35.0 | 37.1 | 1.1 | 13.0 | 11.3 | 42.0 |
 Control-5 | MspI-DpnII | 21.3 | 22.9 | 1.1 | 8.3 | 7.1 | 25.5 |
 LR2–1 | MspI-DpnII | 46.0 | 48.7 | 1.1 | 16.7 | 14.7 | 55.6 |
 LR2–2 | MspI-DpnII | 45.7 | 48.5 | 1.1 | 16.7 | 14.7 | 55.3 |
 LR2–3 | MspI-DpnII | 27.6 | 28.8 | 1.0 | 9.4 | 8.6 | 33.5 |
 LR2–4 | MspI-DpnII | 45.1 | 48.4 | 1.1 | 17.0 | 14.7 | 54.7 |
 LR2–5 | MspI-DpnII | 41.2 | 43.9 | 1.1 | 15.1 | 13.2 | 50.0 |
 Control-6 | MspI-ApeKI | 29.9 | 34.1 | 1.1 | 13.1 | 11.1 | 36.6 |
 Control-7 | MspI-ApeKI | 26.2 | 30.0 | 1.1 | 11.7 | 10.0 | 31.9 |
 Control-8 | MspI-ApeKI | 25.3 | 28.7 | 1.1 | 11.0 | 9.5 | 30.7 |
 Control-9 | MspI-ApeKI | 21.2 | 24.5 | 1.2 | 9.6 | 8.3 | 25.9 |
 Control-10 | MspI-ApeKI | 27.8 | 32.4 | 1.2 | 13.0 | 10.8 | 34.1 |
 LR2–6 | MspI-ApeKI | 23.0 | 26.0 | 1.1 | 9.8 | 8.8 | 27.9 |
 LR2–7 | MspI-ApeKI | 21.8 | 24.9 | 1.1 | 9.5 | 8.5 | 26.5 |
 LR2–8 | MspI-ApeKI | 22.3 | 25.4 | 1.1 | 9.6 | 8.7 | 27.1 |
 LR2–9 | MspI-ApeKI | 23.2 | 26.6 | 1.1 | 10.2 | 9.0 | 28.3 |
 LR2–10 | MspI-ApeKI | 24.0 | 27.1 | 1.1 | 10.0 | 9.0 | 29.3 |
WGBS | Â | Â | Â | Â | Â | Â | Â |
 Control −11 | - | 84.3 | 52.4 | 0.6 | 14.4 | 15.4 | 63.9 |
 LR2–11 | - | 83.7 | 52.6 | 0.6 | 14.5 | 15.6 | 63.9 |